HomeVenture Capital

Venture Capital

Estuary Biotherapeutics Launches with $103 Million to Advance Gene Therapies for Kidney Disease

Life Sciences Times - October 16, 2026

Venture Capital

Acta Pharmaceuticals Raises $24 Million to Advance Alzheimer’s Disease Treatments

Life Sciences Times - October 15, 2026

Venture Capital

Soufflé Therapeutics Raises $135 Million in Series B Financing to Advance RNA Therapies

Life Sciences Times - October 13, 2026

Venture Capital

Consano Bio Raises More Than $15 Million to Advance Chronic Sciatica Therapy

Life Sciences Times - October 5, 2026

Venture Capital

ai3Bio Launches With $48 Million Series A to Advance Autoimmune Disease Therapies

Life Sciences Times - September 29, 2026

Venture Capital

Aphria and Tilray Combine to Create Largest Global Cannabis Company With Pro Forma Revenue of $685 Million

Life Sciences Times - December 16, 2020 0

Venture Capital

Seeqc Announces LG Technology Ventures’ Participation in Series A Funding Round

Life Sciences Times - December 15, 2020 0

Venture Capital

Colorado’s Life Sciences Ecosystem Raises $1.2 Billion in 2020

Life Sciences Times - December 15, 2020 0

Venture Capital

Robotics Specialist German Bionic Receives US $20 Million in Series A Financing

Life Sciences Times - December 14, 2020 0

Venture Capital

ScienceMedia Strikes Investment Deal with Decathlon Capital to Accelerate Clinical Education Platform

Life Sciences Times - December 11, 2020 0

1...113 114115Page 115 of 115

Alnylam Reports Promising Phase 1b Results for Experimental Huntington’s Disease Treatment

October 23, 2026

Zai Lab Reports Promising Early Results for Experimental Small Cell Lung Cancer Treatment

October 23, 2026

Takeda Reports Improved Survival in Phase 3 Trial of Experimental Gastric Cancer Treatment

October 23, 2026

Convergent Therapeutics Reports Promising Phase 2 Results for Prostate Cancer Treatment

October 23, 2026

Venture Capital

Estuary Biotherapeutics Launches with $103 Million to Advance Gene Therapies for Kidney Disease

Acta Pharmaceuticals Raises $24 Million to Advance Alzheimer’s Disease Treatments

Soufflé Therapeutics Raises $135 Million in Series B Financing to Advance RNA Therapies

Consano Bio Raises More Than $15 Million to Advance Chronic Sciatica Therapy

ai3Bio Launches With $48 Million Series A to Advance Autoimmune Disease Therapies

Most Read

Alnylam Reports Promising Phase 1b Results for Experimental Huntington’s Disease Treatment

Zai Lab Reports Promising Early Results for Experimental Small Cell Lung Cancer Treatment

Takeda Reports Improved Survival in Phase 3 Trial of Experimental Gastric Cancer Treatment

Convergent Therapeutics Reports Promising Phase 2 Results for Prostate Cancer Treatment

EDITOR PICKS

eGenesis Names Daniel Leblanc Chief Manufacturing and Supply Officer

Takeda Reports Positive Phase 4 Results for ENTYVIO in Ulcerative Colitis Treatment

Acta Pharmaceuticals Raises $24 Million to Advance Alzheimer’s Disease Treatments

THIS WEEK'S STORIES

BostonGene, Medical University of South Carolina Partner to Advance CAR-T Therapy Research

Genetix Biotherapeutics Appoints Meredith Manning as Chief Commercial Officer

Zai Lab Reports Promising Early Results for Experimental Small Cell Lung Cancer Treatment

POPULAR CATEGORY

ABOUT US

FOLLOW US